Feb 6, 2009 | NEWS
Reykjavik, ICELAND, February 6, 2009 – Scientists at deCODE genetics (Nasdaq:DCGN) today present the discovery of two single letter variations in the sequence of the human genome (SNPs) conferring substantial increased risk of thyroid cancer. The two SNPs, located on...
Feb 3, 2009 | NEWS
deCODEme Cardio™ scan offered at $100 during American heart Month; CEO Kari Stefansson to appear on The Martha Stewart Show this Thursday, February 5th Reykjavik, ICELAND, February 3, 2009 – To mark American Heart Month, deCODE genetics (Nasdaq:DCGN) today announced...
Feb 2, 2009 | NEWS
Finding points directly to a promising target for drug development and has already been integrated into the deCODEme™ genome analysis service Reykjavik, ICELAND, February 2, 2009 – Scientists from deCODE genetics (Nasdaq:DCGN) today report the discovery of the first...
Jan 19, 2009 | NEWS
Findings point to common mechanisms of susceptibility to cancers of the lung, bladder, prostate, cervix and skin; findings to be integrated into deCODEme™, the new deCODEme Cancer Scan™, and deCODE’s DNA-based risk diagnostic tests Reykjavik, ICELAND, January 19, 2009...
Jan 18, 2009 | NEWS
Focused Genetic Scans Offer Individuals a New Way to Better Understand their Risk of Cardiovascular Disease and Common Cancers Reykjavik, ICELAND, January 18, 2009 – Through deCODEme™, the world’s first first retail genome analysis service, deCODE genetics...
Jan 16, 2009 | NEWS
Reykjavik, ICELAND, January 16, 2009 – In a paper published today scientists at deCODE genetics (Nasdaq:DCGN) present the results of the largest study of ancient DNA from a single population ever undertaken. Analyzing mitochondrial DNA, which is passed from mother to...
